Figure 9. Subgroup analyses for first-line SVR12 by ribavirin randomisation.

Note: RAS=resistance associated substitution. All heterogeneity tests also adjusted for the interaction between strategy and fixed-duration vs variable-duration randomisation. Some confidence intervals and heterogeneity p-values could not be estimated due to perfect prediction. All participants with genotype 4 did not receive ribavirin so not included.